Solventum has appointed former Zimmer Biomet executive Rachel Ellingson as chief strategy and corporate development officer.

It’s been almost a year since Solventum spun off as a separate business from 3M. Now, Solventum is orchestrating a spinoff of its own. On Tuesday, Solventum announced that it has lined up a deal ...

Morgan Stanley analyst Patrick Wood maintained a Hold rating on Solventum Corporation (SOLV – Research Report) today and set a price target of ...